Brazil Says AIDS Patent Breaking Is Inspired By US Anthrax Example

“We don’t want to break patents. We want to ensure the sustainability of the STD (sexually transmitted diseases)/AIDS program, and that is why we are trying to negotiate,” affirmed the Ministry of Health’s secretary of Health Surveillance, Jarbas Barbosa.

Barbosa was referring to negotiations with the Merck & Dohme and Gilead Sciences pharmaceutical companies, manufacturers of medicines to combat AIDS.


According to the secretary, the two laboratories have shown receptiveness to the Brazilian government’s proposal to produce the medications for free distribution to AIDS patients.


Abbott Laboratories, the manufacturer of Kaletra, on the other hand, refused to negotiate and has until July 7 to submit a concrete proposal to the government.


Otherwise, the Ministry will declare the patent broken, and Kaletra will be produced by Brazil’s Farmanguinhos laboratory.


The government’s proposal was sent to the three laboratories (Abbott, Gilead Sciences, and Merck & Dohme) on March 14 of this year.


The intention of the government, according to Barbosa, is to lower the costs of producing anti-AIDS cocktails.


“Kaletra is the medication that has the biggest impact on the Ministry of Health’s budget. We spend around US$ 96.9 million (230 million reais) per year.


“It is estimated that domestic production can reduce the current price by up to 50%,” he affirmed. The secretary pointed out that this may encourage less expensive production of new drugs that are being launched.


The representative of the Pan-American Health Organization (PAHO), Horácio Toro, said that patent-breaking will enable the population to have access to cheaper medicines, which will be available to everyone who needs them.


If Brazil produces Kaletra, it is estimated that the unit cost will drop to US$ 0.68, compared with its current price of US$ 1.17.


Barbosa informed that the reaction to patent-breaking has been positive, and he stressed that the measure does not violate legal norms.


“We are in a pioneering position, using complete flexibility. We are not disobeying rules nor tearing up contracts. We are using everything that is stipulated in international trade agreements,” he concluded.


The National Industrial Property Institute (INPI) considers that the possible breaking of the patent on the anti-retroviral drug, Kaletra, by the Ministry of Health should not lead to international sanctions against Brazil.


According to the president of the INPI, Roberto Jaguaribe, “patent-breaking, which really means compulsory licensing, is provided for not only in Brazilian law but also in international instruments, such as the World Trade Organization’s (WTO) Trips Agreement (Agreement on Trade-Related Aspects of Intellectual Property Rights), which foresees this possibility under special circumstances.”


Jaguaribe said that a similar example of patent-breaking “was when the United States permitted multiple compulsory licensing for the production of drugs to combat eventual anthrax attacks in the country.”


ABr – www.radiobras.gov.br

Tags:

You May Also Like

Haiti: Little to Cheer, Much to Fear

When it comes to Haiti, there are few heroes to point to, least of ...

Brazil’s Lula Finally Stops Playing the Blame Game

Brazil’s President Luiz Inácio Lula da Silva is not a happy man at the ...

French Filmmaker Faces 8 Lawsuits in Brazil for Documentary on Fishing Village

French documentary maker José Huerta is facing eight legal proceedings, including one criminal charge, ...

Let Brazilians Sort Out the Problems of the Amazon

The destruction of the Amazon forest is a subject dear to the heart of ...

How Is Brazil Racist? Let Me Count the Ways.

Brazil’s elite has been ashamed of its huge African descent population for centuries and ...

Brazil Building Lab For Testing Cigarettes Ingredients

Brazil will have a research lab for monitoring activities related to tobacco consumption. The ...

Middle East Woos Brazilian Entrepreneurs

The negotiations between entrepreneurs from Brazil and importers and exporters from Iraq, Jordan, Lebanon, ...

Brazil’s Embraer Hands JetBlue First of 101 Jets

Brazilian aircraft manufacturer Embraer delivered today its first Embraer 190 to American airline JetBlue ...

European Painters Worth US$ 50 Million Stolen During Brazil’s Carnaval

A spectacular robbery of art works by Picasso, Matisse, Monet and Dali marred the ...

New Find Places Brazil on World’s Top 10 Oil Producers List

A Brazilian new find, a huge offshore oil discovery, could raise Brazil's petroleum reserves ...